IBDEI1TZ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30651,0)
 ;;=D81.810^^135^1382^5
 ;;^UTILITY(U,$J,358.3,30651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30651,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,30651,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,30651,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,30652,0)
 ;;=E88.01^^135^1382^2
 ;;^UTILITY(U,$J,358.3,30652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30652,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,30652,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,30652,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,30653,0)
 ;;=J09.X1^^135^1382^25
 ;;^UTILITY(U,$J,358.3,30653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30653,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,30653,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,30653,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,30654,0)
 ;;=J09.X2^^135^1382^26
 ;;^UTILITY(U,$J,358.3,30654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30654,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,30654,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,30654,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,30655,0)
 ;;=J09.X3^^135^1382^27
 ;;^UTILITY(U,$J,358.3,30655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30655,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,30655,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,30655,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,30656,0)
 ;;=J09.X9^^135^1382^28
 ;;^UTILITY(U,$J,358.3,30656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30656,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,30656,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,30656,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,30657,0)
 ;;=J44.9^^135^1382^14
 ;;^UTILITY(U,$J,358.3,30657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30657,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,30657,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,30657,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,30658,0)
 ;;=J44.1^^135^1382^12
 ;;^UTILITY(U,$J,358.3,30658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30658,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,30658,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,30658,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,30659,0)
 ;;=J42.^^135^1382^10
 ;;^UTILITY(U,$J,358.3,30659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30659,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,30659,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,30659,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,30660,0)
 ;;=J43.9^^135^1382^22
 ;;^UTILITY(U,$J,358.3,30660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30660,1,3,0)
 ;;=3^Emphysema,Unspec
 ;;^UTILITY(U,$J,358.3,30660,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,30660,2)
 ;;=^5008238
 ;;^UTILITY(U,$J,358.3,30661,0)
 ;;=J43.0^^135^1382^30
 ;;^UTILITY(U,$J,358.3,30661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30661,1,3,0)
 ;;=3^MacLeod's Syndrome
 ;;^UTILITY(U,$J,358.3,30661,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,30661,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,30662,0)
 ;;=J43.1^^135^1382^21
 ;;^UTILITY(U,$J,358.3,30662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30662,1,3,0)
 ;;=3^Emphysema,Panlobular
 ;;^UTILITY(U,$J,358.3,30662,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,30662,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,30663,0)
 ;;=J43.2^^135^1382^19
 ;;^UTILITY(U,$J,358.3,30663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30663,1,3,0)
 ;;=3^Emphysema,Centrilobular
 ;;^UTILITY(U,$J,358.3,30663,1,4,0)
 ;;=4^J43.2
 ;;^UTILITY(U,$J,358.3,30663,2)
 ;;=^5008237
